By OCC Staff
Scientists conducting cannabis research at the SALK Institute in La Jolla, California have found preliminary evidence that compounds in marijuana, which include tetrahydrocannabinol (THC), appear to promote the removal of amyloid beta from cells. Amyloid beta is a toxic protein that has been associated with Alzheimer’s disease. That’s right, cannabis may treat Alzheimer’s Disease.
The article was published in June 2016’s Aging and Mechanisms of Disease. The Salk team’s findings were conducted in exploratory laboratory models only, and Schubert stressed, “The use of THC-like compounds as a therapy would need to be tested in clinical trials.”
From the Salk Institute:
“Salk Institute scientists have found preliminary evidence that tetrahydrocannabinol (THC) and other compounds found in marijuana can promote the cellular removal of amyloid beta, a toxic protein associated with Alzheimer’s disease.
“While these exploratory studies were conducted in neurons grown in the laboratory, they may offer insight into the role of inflammation in Alzheimer’s disease and could provide clues to developing novel therapeutics for the disorder.
“’Although other studies have offered evidence that cannabinoids might be neuroprotective against the symptoms of Alzheimer’s, we believe our study is the first to demonstrate that cannabinoids affect both inflammation and amyloid beta accumulation in nerve cells,’ says Salk Professor David Schubert, the senior author of the paper.”
© 2016 Oregon Cannabis Connection. All Rights Reserved.